244 related articles for article (PubMed ID: 35955521)
1. TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases.
Kim JE; Kim E; Lee JW
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955521
[TBL] [Abstract][Full Text] [Related]
2. TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment.
Kim E; Um H; Park J; Jung JW; Kim JE; Lee H; Shin EA; Pinanga Y; Lee H; Nam SH; Lee JW
Cell Rep; 2021 Nov; 37(7):110018. PubMed ID: 34788612
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis.
Lee H; Kim E; Shin EA; Shon JC; Sun H; Kim JE; Jung JW; Lee H; Pinanga Y; Song DG; Liu KH; Lee JW
Mol Metab; 2022 Apr; 58():101451. PubMed ID: 35123128
[TBL] [Abstract][Full Text] [Related]
4. Tetraspanin TM4SF5 in hepatocytes negatively modulates SLC27A transporters during acute fatty acid supply.
Park D; Kim E; Lee H; Shin EA; Lee H; Lee JW
Arch Biochem Biophys; 2021 Oct; 710():109004. PubMed ID: 34364885
[TBL] [Abstract][Full Text] [Related]
5. Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities.
Kang M; Ryu J; Lee D; Lee MS; Kim HJ; Nam SH; Song HE; Choi J; Lee GH; Kim TY; Lee H; Kim SJ; Ye SK; Kim S; Lee JW
PLoS One; 2014; 9(7):e102817. PubMed ID: 25033048
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis.
Lee SA; Kim TY; Kwak TK; Kim H; Kim S; Lee HJ; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
J Cell Biochem; 2010 Sep; 111(1):59-66. PubMed ID: 20506553
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
8. N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application.
Song HE; Lee Y; Kim E; Cho CY; Jung O; Lee D; Lee EG; Nam SH; Kang M; Macalino SJY; Kim JE; Jung JW; Kwon SW; Choi S; Lee JW
Theranostics; 2021; 11(16):8092-8111. PubMed ID: 34335982
[TBL] [Abstract][Full Text] [Related]
9. Deranged hepatocyte intracellular Ca
Ali ES; Rychkov GY; Barritt GJ
Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
[TBL] [Abstract][Full Text] [Related]
10. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
12. Glucose-mediated mitochondrial reprogramming by cholesterol export at TM4SF5-enriched mitochondria-lysosome contact sites.
Kim JE; Park SY; Kwak C; Lee Y; Song DG; Jung JW; Lee H; Shin EA; Pinanga Y; Pyo KH; Lee EH; Kim W; Kim S; Jun CD; Yun J; Choi S; Rhee HW; Liu KH; Lee JW
Cancer Commun (Lond); 2024 Jan; 44(1):47-75. PubMed ID: 38133457
[TBL] [Abstract][Full Text] [Related]
13. Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
Lee D; Na J; Ryu J; Kim HJ; Nam SH; Kang M; Jung JW; Lee MS; Song HE; Choi J; Lee GH; Kim TY; Chung JK; Park KH; Kim SH; Kim H; Seo H; Kim P; Youn H; Lee JW
Hepatology; 2015 Jun; 61(6):1978-97. PubMed ID: 25627085
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between integrin alpha5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity.
Choi S; Lee SA; Kwak TK; Kim HJ; Lee MJ; Ye SK; Kim SH; Kim S; Lee JW
Blood; 2009 Feb; 113(8):1845-55. PubMed ID: 19036703
[TBL] [Abstract][Full Text] [Related]
15. TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes.
Sun H; Kim E; Ryu J; Lee H; Shin EA; Lee M; Lee H; Lee JH; Yoon JH; Song DG; Kim S; Lee JW
Cell Mol Life Sci; 2021 Dec; 79(1):49. PubMed ID: 34921636
[TBL] [Abstract][Full Text] [Related]
16. Amino acid transporters as tetraspanin TM4SF5 binding partners.
Jung JW; Kim JE; Kim E; Lee JW
Exp Mol Med; 2020 Jan; 52(1):7-14. PubMed ID: 31956272
[TBL] [Abstract][Full Text] [Related]
17. TM4SF5-mediated abnormal food-intake behavior and apelin expression facilitate non-alcoholic fatty liver disease features.
Pinanga YD; Lee HA; Shin EA; Lee H; Pyo KH; Kim JE; Lee EH; Kim W; Kim S; Kim HY; Lee JW
iScience; 2023 Sep; 26(9):107625. PubMed ID: 37670786
[TBL] [Abstract][Full Text] [Related]
18. Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.
Moreno-Fernandez ME; Giles DA; Stankiewicz TE; Sheridan R; Karns R; Cappelletti M; Lampe K; Mukherjee R; Sina C; Sallese A; Bridges JP; Hogan SP; Aronow BJ; Hoebe K; Divanovic S
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563328
[TBL] [Abstract][Full Text] [Related]
19. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
